Sionna Therapeutics (SION) Total Liabilities (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Total Liabilities data on file, last reported at $16.8 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 6.0% year-over-year to $16.8 million; the trailing twelve-month figure through Mar 2026 stood at $16.8 million (down 6.0% YoY), and the FY2025 full-year result was $19.1 million, changed 0.12% from the prior year.
• Total Liabilities retreated to $16.8 million in Q1 2026, from $19.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $19.1 million in Q4 2025 to a low of $15.6 million in Q2 2025.
• A 3-year average of $17.7 million and a median of $17.8 million in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities grew 0.12% in 2025 and fell 6.0% in 2026, its largest moves.
• Tracing SION's Total Liabilities over 3 years: stood at $19.1 million in 2024, then gained by 0.12% to $19.1 million in 2025, then retreated by 11.97% to $16.8 million in 2026.
• Business Quant data shows SION's Total Liabilities at $16.8 million in Q1 2026, $19.1 million in Q4 2025, and $17.6 million in Q3 2025.